share_log

JMP Securities Reiterates Market Outperform on OptimizeRx, Maintains $15 Price Target

Moomoo 24/7 ·  Apr 16 11:18

JMP Securities analyst Constantine Davides reiterates OptimizeRx (NASDAQ:OPRX) with a Market Outperform and maintains $15 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment